Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dan H, Barouch"'
Autor:
Michelle Liu, Kenneth H. Eckles, Matthew C. Wise, Heather Friberg, Peter Abbink, Rafael De La Barrera, Bridget S. Lewis, Stephen J. Thomas, Lindsey S. Garver, Mark Milazzo, Dan H. Barouch, Kayvon Modjarrad, David Jetton, Jeffrey R. Currier, Anna B. Mullins, Michael K. McCracken, Richard G. Jarman, J. Robert Putnak, Gregory D. Gromowski, Nelson L. Michael, Xiaoxu Lin, Michael R. Boyd
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 13, Iss 8, p e1006487 (2017)
PLoS Pathogens, Vol 13, Iss 8, p e1006487 (2017)
Studies have demonstrated cross-reactivity of anti-dengue virus (DENV) antibodies in human sera against Zika virus (ZIKV), promoting increased ZIKV infection in vitro. However, the correlation between in vitro and in vivo findings is not well charact
Autor:
Todd J. Suscovich, Lindsey R. Baden, Maria Pau, Dagna Laufer, Hanneke Schuitemaker, Bruce D. Walker, Hendrik Streeck, Patricia E. Fast, Dan H. Barouch, Donald P. Francis, Kendall Dionne, Alison E. Mahan, Amy W. Chung, Galit Alter, Madeleine F. Jennewein, Jacquelynne Tedesco
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 6, p e1005694 (2016)
PLoS Pathogens, Vol 12, Iss 6, p e1005694 (2016)
Antibody effector functions, such as antibody-dependent cellular cytotoxicity, complement deposition, and antibody-dependent phagocytosis, play a critical role in immunity against multiple pathogens, particularly in the absence of neutralizing activi
Autor:
Michel C. Nussenzweig, Jetta Garrity, John R. Mascola, Tanmoy Bhattacharya, Hyejin Yoon, Salim S. Abdool Karim, Alexander. Robles, David C. Montefiori, Michael Rist, Bette T. Korber, Lynn Morris, Dennis R. Burton, Alan Lapedes, Mark K. Louder, Kelli Greene, Michael S. Seaman, Carolyn Williamson, Cecilia Rademeyer, Dan H. Barouch, Rui Kong, Hongmei Gao, Madeleine Bayne, Kshitij Wagh
Publikováno v:
PLoS One
PLoS Pathogens, Vol 12, Iss 3, p e1005520 (2016)
PLoS Pathogens
PLoS Pathogens, Vol 12, Iss 3, p e1005520 (2016)
PLoS Pathogens
The identification of a new generation of potent broadly neutralizing HIV-1 antibodies (bnAbs) has generated substantial interest in their potential use for the prevention and/or treatment of HIV-1 infection. While combinations of bnAbs targeting dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf5db8533ce4b77710a56f9eaeb07fc